REGISTER
SIGN IN
CureSight
MPIN: MP47799
Sign in to view priceAmblyopia (Lazy-eye) affects 3% of all population and puts the patients at risk for eventual vision loss.
Gold Standard treatment for lazy eye is placing a patch over the strong eye – an archaic solution which suffers from very low compliance.
With the CureSight™ binocular treatment, children develop stereoscopic vision, which is difficult to be achieved with the monocular nature of the traditional patching treatment.
Ask for Quote
CureSight
Eye Tracking Based Amblyopia Treatment
Amblyopia (Lazy-eye) affects 3% of all population and puts the patients at risk for eventual vision loss.
Gold Standard treatment for lazy eye is placing a patch over the strong eye – an archaic solution which suffers from very low compliance.
With the CureSight binocular treatment, children develop stereoscopic vision, which is difficult to be achieved with the monocular nature of the traditional patching treatment.
Shipping Policy
Orders made at Medpick are initiated and processed for shipment upon receipt of request from the customer. Please note that our Shipping Services (Fee, Transportation, Loss or Damage of any shipment, etc.) are in accordance with the Seller\'s terms of Shipment.
Refund Policy
Please refer to Medpick Return Policy.
Cancellation / Return / Exchange Policy
Please refer to Medpick Return Policy.
Related products
-
Consumer Goods, Disability and Extensions, Health Innovations, Incontinece
DFree Bundle
DFree is a first wearable device to predict when you need to go to the toilet. It is for seniors and people with disability who suffer from loss of bladder control. This wearable device will continuously monitor your bladder and notify when your bladder is almost full so you know when to go resulting in less “accidents.”
SKU: MP28234
